IVBXF
Price
$12.13
Change
-$0.15 (-1.22%)
Updated
Sep 25 closing price
Capitalization
20.9B
IVEVF
Price
$2.28
Change
-$1.36 (-37.36%)
Updated
Feb 12 closing price
Capitalization
768M
Interact to see
Advertisement

IVBXF vs IVEVF

Header iconIVBXF vs IVEVF Comparison
Open Charts IVBXF vs IVEVFBanner chart's image
Innovent Biologics
Price$12.13
Change-$0.15 (-1.22%)
Volume$787
Capitalization20.9B
INVENTIVA SA
Price$2.28
Change-$1.36 (-37.36%)
Volume$1K
Capitalization768M
IVBXF vs IVEVF Comparison Chart in %
Loading...
IVBXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IVBXF vs. IVEVF commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IVBXF is a Hold and IVEVF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (IVBXF: $12.14 vs. IVEVF: $2.28)
Brand notoriety: IVBXF and IVEVF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IVBXF: 1% vs. IVEVF: 100%
Market capitalization -- IVBXF: $20.9B vs. IVEVF: $768M
IVBXF [@Biotechnology] is valued at $20.9B. IVEVF’s [@Biotechnology] market capitalization is $768M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IVBXF’s FA Score shows that 0 FA rating(s) are green whileIVEVF’s FA Score has 0 green FA rating(s).

  • IVBXF’s FA Score: 0 green, 5 red.
  • IVEVF’s FA Score: 0 green, 5 red.
According to our system of comparison, IVBXF is a better buy in the long-term than IVEVF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IVBXF’s TA Score shows that 3 TA indicator(s) are bullish.

  • IVBXF’s TA Score: 3 bullish, 5 bearish.

Price Growth

IVBXF (@Biotechnology) experienced а -3.69% price change this week, while IVEVF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.69%. For the same industry, the average monthly price growth was +9.02%, and the average quarterly price growth was +51.46%.

Industries' Descriptions

@Biotechnology (+3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IVBXF($20.9B) has a higher market cap than IVEVF($768M). IVBXF YTD gains are higher at: 169.667 vs. IVEVF (-37.363).
IVBXFIVEVFIVBXF / IVEVF
Capitalization20.9B768M2,721%
EBITDAN/AN/A-
Gain YTD169.667-37.363-454%
P/E Ratio128.82N/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
IVBXF: Fundamental Ratings
IVBXF
OUTLOOK RATING
1..100
97
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
PROFIT vs RISK RATING
1..100
66
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
61
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IVBXFIVEVF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
70%
N/A
Momentum
ODDS (%)
Bearish Trend 2 days ago
64%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
61%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
64%
Bullish Trend 2 days ago
12%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
61%
Bullish Trend 2 days ago
12%
Advances
ODDS (%)
Bullish Trend 15 days ago
72%
N/A
Declines
ODDS (%)
Bearish Trend 19 days ago
56%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
67%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
61%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
IVBXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSIBX21.14N/A
N/A
Morgan Stanley Inst Passport ovrs eq A
KTRZX9.55N/A
N/A
DWS Global Income Builder R6
TECHX23.03N/A
N/A
WisdomTree Technology and Inn 100 DgtN/A
FSENX62.83N/A
N/A
Fidelity Select Energy Portfolio
CSJAX67.39N/A
N/A
Cohen & Steers Realty Shares A

IVBXF and

Correlation & Price change

A.I.dvisor tells us that IVBXF and WXXWY have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IVBXF and WXXWY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IVBXF
1D Price
Change %
IVBXF100%
-1.26%
WXXWY - IVBXF
22%
Poorly correlated
+1.92%
ONC - IVBXF
22%
Poorly correlated
-0.34%
MDWD - IVBXF
20%
Poorly correlated
-1.78%
IVEVF - IVBXF
15%
Poorly correlated
N/A
INTI - IVBXF
11%
Poorly correlated
+13.63%
More

IVEVF and

Correlation & Price change

A.I.dvisor tells us that IVEVF and DTIL have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IVEVF and DTIL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IVEVF
1D Price
Change %
IVEVF100%
N/A
DTIL - IVEVF
32%
Poorly correlated
-3.90%
MIST - IVEVF
28%
Poorly correlated
+1.55%
IDRSF - IVEVF
21%
Poorly correlated
N/A
INTI - IVEVF
17%
Poorly correlated
+13.63%
INNMF - IVEVF
15%
Poorly correlated
+8.27%
More